glp 1's The Latest on GLP-1s | Lexington Medical Center Blog What is GLP-1? The Hormone

2.8% [4.7]

Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are emerging glucose-lowering agents primarily used in managing diabetes and obesity

The European Cardiovascular Health Plan Roadmap from the European Alliance was published earlier in 2025 and calls for comprehensive approaches to incorporate the recognition of obesity as a trigger for cardiovascular disease

NP-supervised, in-person care

When you eat, your digestive system breaks carbohydrates into glucose, which then enters your bloodstream

Although, in the last 10 years, the use of GLP-1 RAs, especially semaglutide and liraglutide, has increased, its clinical implications and how it affects metabolic parameters have yet to be fully consolidated